203 related articles for article (PubMed ID: 22753749)
1. In vitro cytotoxic activity of novel protoflavone analogs - selectivity towards a multidrug resistant cancer cell line.
Danko B; Martins A; Chuang DW; Wang HC; Amaral L; Molnár J; Chang FR; Wu YC; Hunyadi A
Anticancer Res; 2012 Jul; 32(7):2863-9. PubMed ID: 22753749
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and SAR Study of Anticancer Protoflavone Derivatives: Investigation of Cytotoxicity and Interaction with ABCB1 and ABCG2 Multidrug Efflux Transporters.
Dankó B; Tóth S; Martins A; Vágvölgyi M; Kúsz N; Molnár J; Chang FR; Wu YC; Szakács G; Hunyadi A
ChemMedChem; 2017 Jun; 12(11):850-859. PubMed ID: 28436164
[TBL] [Abstract][Full Text] [Related]
3. Antitumor agents 260. New desmosdumotin B analogues with improved in vitro anticancer activity.
Nakagawa-Goto K; Bastow KF; Chen TH; Morris-Natschke SL; Lee KH
J Med Chem; 2008 Jun; 51(11):3297-303. PubMed ID: 18473435
[TBL] [Abstract][Full Text] [Related]
4. Direct semi-synthesis of the anticancer lead-drug protoapigenone from apigenin, and synthesis of further new cytotoxic protoflavone derivatives.
Hunyadi A; Chuang DW; Danko B; Chiang MY; Lee CL; Wang HC; Wu CC; Chang FR; Wu YC
PLoS One; 2011; 6(8):e23922. PubMed ID: 21912610
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxicity studies of some novel fluoro acridone derivatives against sensitive and resistant cancer cell lines and their mechanistic studies.
Rajendra Prasad VV; Peters GJ; Lemos C; Kathmann I; Mayur YC
Eur J Pharm Sci; 2011 Jul; 43(4):217-24. PubMed ID: 21565270
[TBL] [Abstract][Full Text] [Related]
6. Significant activity of ecdysteroids on the resistance to doxorubicin in mammalian cancer cells expressing the human ABCB1 transporter.
Martins A; Tóth N; Ványolós A; Béni Z; Zupkó I; Molnár J; Báthori M; Hunyadi A
J Med Chem; 2012 Jun; 55(11):5034-43. PubMed ID: 22578055
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and structure-activity relationships of taxuyunnanine C derivatives as multidrug resistance modulator in MDR cancer cells.
Hasegawa T; Bai J; Dai J; Bai L; Sakai J; Nishizawa S; Bai Y; Kikuchi M; Abe M; Yamori T; Tomida A; Tsuruo T; Hirose K; Ando M
Bioorg Med Chem Lett; 2007 Jul; 17(13):3722-8. PubMed ID: 17490878
[TBL] [Abstract][Full Text] [Related]
8. 8,11-dihydroxy-6-[(aminoalkyl)amino]-7H-benzo[e]perimidin-7-ones with activity in multidrug-resistant cell lines: synthesis and antitumor evaluation.
Stefańska B; Dzieduszycka M; Bontemps-Gracz MM; Borowski E; Martelli S; Supino R; Pratesi G; De Cesare M; Zunino F; Kuśnierczyk H; Radzikowski C
J Med Chem; 1999 Sep; 42(18):3494-501. PubMed ID: 10479282
[TBL] [Abstract][Full Text] [Related]
9. Antitumor agents 253. Design, synthesis, and antitumor evaluation of novel 9-substituted phenanthrene-based tylophorine derivatives as potential anticancer agents.
Wei L; Shi Q; Bastow KF; Brossi A; Morris-Natschke SL; Nakagawa-Goto K; Wu TS; Pan SL; Teng CM; Lee KH
J Med Chem; 2007 Jul; 50(15):3674-80. PubMed ID: 17585747
[TBL] [Abstract][Full Text] [Related]
10. New silicon compounds as resistance modifiers against multidrug-resistant cancer cells.
Molnar J; Mucsi I; Nacsa J; Hevér A; Gyémánt N; Ugocsai K; Hegyes P; Kiessig S; Gaal D; Lage H; Varga A
Anticancer Res; 2004; 24(2B):865-71. PubMed ID: 15161039
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of anticancer effects of newly synthesized dihydropyridine derivatives in comparison to verapamil and doxorubicin on T47D parental and resistant cell lines in vitro.
Bazargan L; Fouladdel S; Shafiee A; Amini M; Ghaffari SM; Azizi E
Cell Biol Toxicol; 2008 Apr; 24(2):165-74. PubMed ID: 17805981
[TBL] [Abstract][Full Text] [Related]
12. Lower antioxidative capacity of multidrug-resistant cancer cells confers collateral sensitivity to protoflavone derivatives.
Stanković T; Dankó B; Martins A; Dragoj M; Stojković S; Isaković A; Wang HC; Wu YC; Hunyadi A; Pešić M
Cancer Chemother Pharmacol; 2015 Sep; 76(3):555-65. PubMed ID: 26198315
[TBL] [Abstract][Full Text] [Related]
13. Protoapigenone derivatives: albumin binding properties and effects on HepG2 cells.
Poór M; Li Y; Kunsági-Máté S; Varga Z; Hunyadi A; Dankó B; Chang FR; Wu YC; Kőszegi T
J Photochem Photobiol B; 2013 Jul; 124():20-6. PubMed ID: 23648796
[TBL] [Abstract][Full Text] [Related]
14. Novel multidrug resistance reversal agents.
Berger D; Citarella R; Dutia M; Greenberger L; Hallett W; Paul R; Powell D
J Med Chem; 1999 Jun; 42(12):2145-61. PubMed ID: 10377220
[TBL] [Abstract][Full Text] [Related]
15. Anticancer SAR models for MCF-7 and MDA-MB-231 breast cell lines.
Qamar S; Carrasquer CA; Cunningham SL; Cunningham AR
Anticancer Res; 2011 Oct; 31(10):3247-52. PubMed ID: 21965732
[TBL] [Abstract][Full Text] [Related]
16. Overcoming multidrug resistance (MDR) in cancer in vitro and in vivo by a quinoline derivative.
Ganguly A; Banerjee K; Chakraborty P; Das S; Sarkar A; Hazra A; Banerjee M; Maity A; Chatterjee M; Mondal NB; Choudhuri SK
Biomed Pharmacother; 2011 Sep; 65(6):387-94. PubMed ID: 21715129
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of some novel benzofuran-2-yl(4,5-dihyro-3,5-substituted diphenylpyrazol-1-yl) methanones and studies on the antiproliferative effects and reversal of multidrug resistance of human MDR1-gene transfected mouse lymphoma cells in vitro.
Parekh S; Bhavsar D; Savant M; Thakrar S; Bavishi A; Parmar M; Vala H; Radadiya A; Pandya N; Serly J; Molnár J; Shah A
Eur J Med Chem; 2011 May; 46(5):1942-8. PubMed ID: 21396744
[TBL] [Abstract][Full Text] [Related]
18. Multidrug resistance reverting activity and antitumor profile of new phenothiazine derivatives.
Bisi A; Meli M; Gobbi S; Rampa A; Tolomeo M; Dusonchet L
Bioorg Med Chem; 2008 Jul; 16(13):6474-82. PubMed ID: 18522868
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive study of sansalvamide A derivatives and their structure-activity relationships against drug-resistant colon cancer cell lines.
Otrubova K; Lushington G; Vander Velde D; McGuire KL; McAlpine SR
J Med Chem; 2008 Feb; 51(3):530-44. PubMed ID: 18186604
[TBL] [Abstract][Full Text] [Related]
20. Diorganotin(IV) derivatives of substituted N-hydroxybenzamides with selective cytotoxicity in vitro and potent antitumor activity in vivo.
Li YL; Wang ZW; Guo P; Tang L; Ge R; Ban SR; Chai QY; Niu L; Li QS
J Inorg Biochem; 2014 Apr; 133():1-7. PubMed ID: 24413257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]